10:50am ET
Health and Healthcare
Why Biogen Is Now a Buy on Weakness
Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.
Chris Lange BIIB Coverage Page 25
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Biogen, GoPro, Intel, Micron, SunPower and More
Tuesday's top analyst upgrades, downgrades and initiations include Amazon.com, Biogen, GoPro, Intel, Micron Technology and SunPower.
7:55am ET
Health and Healthcare
Short Sellers Back Off Big Biotech
24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.
12:35pm ET
Health and Healthcare
Biogen Loses Its Head of Research and Development
Biogen announced on Friday that it is losing its head of research and development at the end of July.
Jon C. Ogg 7:50am ET
Health and Healthcare
Short Sellers Get More Selective on Big Biotech
The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech stocks was mixed.
7:55am ET
Health and Healthcare
Short Sellers Lose Some Conviction Against Big Biotech
The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech stocks, short interest has decreased.
8:25am ET
Health and Healthcare
Short Sellers Get Even More Ambitious Against Biotech Leaders
The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of stocks.
8:05am ET
Health and Healthcare
Short Sellers Start to Get Nervous on Biotech
The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks, short interest is down.
9:15am ET
Investing
Credit Suisse Adds New Stocks to Buy to Top Picks List
The higher the market goes, the harder it is for investors to know what to do. One good strategy is to always buy stocks that are the highest conviction picks at a…
8:30am ET
Health and Healthcare
Short Sellers Become More Wary of Big Biotech
The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
9:45am ET
Health and Healthcare
Will Biogen Earnings Interrupt the Biotech Bull Market?
Biogen reported disappointing first-quarter financials before the markets opened Friday.
Chris Lange 8:35am ET
Health and Healthcare
Short Sellers Increase Their Bets Against Biotech Stocks
The March 31 short interest data have been compared with the March 13 figures, and for most of the selected biotech stocks, short interest has increased.
8:35am ET
Health and Healthcare
RBC Has 4 Biotech Stocks to Buy After Massive Pullback
In a new report from RBC, while they think the selling and profit taking in biotechs could go on, they also hold fast that industry fundamentals are still very positive.
7:25am ET
Investing
7 Companies That Seriously Should Split Their Stocks
While investors have been enjoying ever higher dividends and buybacks at a new record, you just do not see waves and waves of stock splits any longer.
9:15am ET
Health and Healthcare
Major Biotech Is So-So for Short Sellers
The March 13 short interest data in top biotechs have been compared with the end of February figures, and across the board all the selected stocks have seen their short interest increase.